Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Uroconnect Follow Up Group.
- Who it may be relevant to
- Registry conditions: Digitizing Perioperative Nursing Coordination. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination
Overview
The project proposes to evaluate the interest of the UroConnect remote monitoring Medical Device (DM) to optimize patient support and nursing coordination
Detailed description
Kidney cancer represents 2 to 3% of solid cancers in adults. Worldwide, an estimated 431,288 people a year are diagnosed with kidney cancer. Each year, in France, 13,500 patients undergo total or partial nephrectomy. The development of minimally invasive surgical techniques and the structuring of innovative care pathways for the management of renal tumors in Enhanced Rehabilitation After Surgery (RAAC) and even on an outpatient basis have led to a significant reduction in the length of stays. The physiognomy of the course of care for patients operated on for a renal tumor is completely modified and generates for the patient a feeling of deterioration in the quality of care and disruption of medical follow-up.
The objective is to deploy a model for coordinating the perioperative care pathway of patients who have undergone nephrectomy for renal tumor in several French centers in order to assess the impact for patients, caregivers and the health system.
This coordination would lead to the formalization of a nurse coordinator job profile adapted to the specificities of oncological surgery and the tools necessary for its implementation. The UroConnect device has a "patient" interface for presenting self-questionnaires and access to a library of educational content and a "caregiver" interface to rationalize and optimize the nurse's activity of perioperative coordination in his task.
Interventions
- Other Uroconnect Follow Up Group
Inplementation of UroConnect remote monitoring Medical Device (DM) to optimize patient support and nursing coordination.
Primary outcome measures
- Number of unscheduled and uncoordinated care utilizations [Time frame: 30 post-operative days]
Secondary outcome measures (9)
- Patient anxiety evaluation [Time frame: Day-1]
- Hospitalised patient satisfaction and experience evaluation [Time frame: Day-30 post-op]
- Nature and reasons for seeking care [Time frame: Day 30]
- Average length of stay [Time frame: Day 30]
- UroConnect usage [Time frame: Month 24]
- Nursing coordination activity linked to UroConnect [Time frame: Month 24]
- Qualitative analysis of the obstacles and levers to appropriation of UroConnect [Time frame: Month 24]
- Differential real cost for the Hospital [Time frame: Month 24]
- Differential cost-consequence ratio [Time frame: Day 30]
Eligibility criteria
Inclusion criteria
- Planned surgical management by total or partial nephrectomy for kidney tumor,
- Affiliation or beneficiary of the French social security
- Expressed consent for integration of the UroCCR cohort,
- Expressed consent to participate in the DiPRU study.
Exclusion criteria
- Difficulties understanding and expressing oneself in French
- Participant under guardianship or curatorship
- Pregnancy at the time of surgery
- No internet access
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Sequential
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
France · 11 centers
- CHU d'Angers — Angers
- CHU de Bordeaux — Bordeaux
- Centre Catalan d'Urologie — Cabestany
- CHU de Caen — Caen
- Hôpital Henri Mondor — Créteil
- APHM — Marseille
- CH de Mont de Marsan — Mont-de-Marsan
- CHU de Nantes — Nantes
- … and 3 more centers
Identifiers
NCT: NCT06047600 · CHUBX2022/77